Evidence map›Paper›PMID 41861066›Full record

ReviewCardiovascular research2026

The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension.

Marek Rajzer, Wiktoria Wojciechowska, Andrzej Januszewicz, Yu-Ling Yu, Ji-Guang Wang, Omar Hahad, Andreas Daiber, Manuel Spitschan, Philippe van de Borne, Bojan Jelaković and 11 more

Abstract readReviewConsensus Statement
In one paragraph

Review in Cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bedroom Air Purification and Home Blood Pressure.Journal of clinical hypertension (Greenwich, Conn.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Marek RajzerFirst Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.ORCID 0000-0001-7074-7263
Wiktoria WojciechowskaFirst Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.ORCID 0000-0003-3075-3508
Andrzej JanuszewiczDepartment of Hypertension, National Institute of Cardiology, Warszawa, Poland.ORCID 0000-0002-1831-250X
Yu-Ling YuNon-Profit Research Association Alliance for the Promotion of Preventive Medicine, Mechelen, Belgium.
Ji-Guang WangThe Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Omar HahadDepartment of Cardiology-Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID 0000-0001-7823-7671
Andreas DaiberGerman Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.ORCID 0000-0002-2769-0094
Manuel SpitschanDepartment Health and Sport Sciences, Technical University of Munich, TUM School of Medicine and Health, Chronobiology & Health, Munich, Germany.ORCID 0000-0002-8572-9268
Philippe van de BorneDepartment of Cardiology ULB-HUB Erasme, Brussels, Belgium.ORCID 0000-0002-5693-1045
Bojan JelakovićDepartment of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, Zagreb, Croatia.ORCID 0000-0002-2546-4632
Ana JelakovićDepartment of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, Zagreb, Croatia.ORCID 0000-0002-9262-4667
De-Wei AnNon-Profit Research Association Alliance for the Promotion of Preventive Medicine, Mechelen, Belgium.
Xiao-Fei YeThe Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Grzegorz K JakubiakDepartment of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.ORCID 0000-0003-0039-8306
Michel BurnierFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-1283-8487
Alexandre PersuDepartment of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.ORCID 0000-0002-4007-9695
Thomas WeberCardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria.ORCID 0000-0003-0617-0417
Tomasz J GuzikCentre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Reinhold KreutzInstitute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-4818-211X
Thomas MünzelDepartment of Cardiology-Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Jan A StaessenFirst Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.ORCID 0000-0002-3026-1637

Funding

OMRON Healthcare Co Ltd, Kyoto, Japan
6 · The paper itself

Abstract

Environmental pollution-including air, noise, and light-and progressive climate change are major contributors to global health burdens, responsible for over 9 million premature deaths annuallysa. Among environmental exposures, air and noise pollution show the strongest epidemiological links to hypertension and cardiovascular disease, while emerging evidence also implicates light pollution, toxic metal exposure, and climate-related factors. Hypertension, the leading global cause of mortality, is increasingly recognized as a sentinel marker of environmental damage. Fine particulate matter (PM2.5) and road traffic noise exposure are associated with significant increase in hypertension prevalence and incidence. While historical guidelines overlooked environmental contributors, recent updates by the European Society of Hypertension (ESH) and European Society of Cardiology (ESC) have integrated environmental risk factors into hypertension management frameworks. This position paper from the ESH Working Group on Environment and Hypertension synthesizes current evidence on the epidemiology and pathophysiology of environmental pollution in the development of hypertension. It highlights the mechanistic pathways involving oxidative stress, vascular dysfunction, and neurohormonal dysregulation triggered by pollution exposure. Importantly, the paper outlines mitigation strategies at both population and individual levels, including legislative initiatives, urban planning, and personal exposure reduction techniques. Considering hypertension as an early manifestation of environmental harm offers a critical opportunity for preventive intervention. It is vital to emphasize strict blood pressure control, enhanced screening in high-risk populations and the integration of environmental exposure monitoring into clinical practice. This comprehensive document seeks to raise awareness among healthcare professionals and inform evidence-based strategies for reducing pollution-related hypertension and cardiovascular morbidity.

Indexed as

Blood PressureClimate ChangeEnvironmental ExposureEnvironmental PollutionHypertensionAnimalsHumansPrevalenceRisk AssessmentRisk FactorsAir pollutionClimate changeEnvironmental pollutionHypertensionLight pollutionMitigation strategiesNoise pollutionPosition paper

Identifiers

PMID41861066
PMCPMC13196876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.